Dimethyl fumarate as a treatment for multiple sclerosis : a role for mitochondria?
Multiple sclerosis (MS) is a debilitating neurological disease, characterized by inflammatory, demyelinating lesions in the central nervous system (CNS). Dimethyl fumarate (DMF), an approved therapy for MS, is thought to act via anti-inflammatory and anti-oxidant mechanisms, specifically via the tra...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
University College London (University of London)
2018
|
| Subjects: | |
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.747466 |